BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,826,000 | +18.5% | 303,642 | -0.5% | 0.07% | +15.5% |
| Q2 2022 | $3,229,000 | -41.4% | 305,157 | -10.0% | 0.06% | +13.7% |
| Q1 2022 | $5,512,000 | +16.8% | 339,009 | -0.5% | 0.05% | +88.9% |
| Q4 2021 | $4,720,000 | +4.7% | 340,779 | +8.6% | 0.03% | +17.4% |
| Q3 2021 | $4,509,000 | -9.0% | 313,806 | +0.1% | 0.02% | -4.2% |
| Q2 2021 | $4,955,000 | +130.5% | 313,393 | +48.2% | 0.02% | +100.0% |
| Q1 2021 | $2,150,000 | +5.7% | 211,407 | -64.3% | 0.01% | -7.7% |
| Q3 2020 | $2,034,000 | – | 592,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |